![]() Xtant Medical Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. | ![]() ACell ACell is a company focused on the development and commercialization of medical devices for wound management and surgical soft tissue repair. | |||
Founding Date | Founding Date 2006 | Founding Date 2002 | Founding Date 1992 | Founding Date 1991 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Belgrade, US HQ Miamisburg, US | Locations Columbia, US HQ Lafayette, US | Locations Chichester, GB HQ | Locations Boulder, US HQ |
Employees | Employees 14115% decrease | Employees 400 | Employees 24 | Employees 3413% increase |
Valuation ($) | Valuation ($) 77.1 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 5.6 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $133.9m (FY, 2025) | Revenue (est.) $100.8m (FY, 2019) | Revenue (est.) £2.1m (FY, 2024) | Revenue (est.) $6.6m (FY, 2025) |
Cost of goods | Cost of goods $49.7m (FY, 2025) | Cost of goods $19.1m (FY, 2019) | Cost of goods £419k (FY, 2024) | Cost of goods $3m (FY, 2025) |
Gross profit | Gross profit $84.3m (FY, 2025) | Gross profit $81.7m (FY, 2019) | Gross profit £1.6m (FY, 2024) | Gross profit $3.5m (FY, 2025) |
Net income | Net income $5m (FY, 2025) | Net income $1.4m (FY, 2019) | Net income (£1.8m) (FY, 2024) | Net income ($220.2k) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 8.7m | Total funding raised N/A | Total funding raised $ 12m |

ACell is a company focused on the development and commercialization of medical devices for wound management and surgical soft tissue repair.
View company
Deltex Medical manufactures and markets haemodynamic monitoring technologies.
View company
Encision is a medical device company that develops laparoscopic surgical instruments.
View company